Cortisone Market is expected to reach USD 1.54 billion by year 2026| Pfizer Inc., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Perrigo Company plc, etc.

According to the current analysis of Reports and Data, the global Cortisone market was valued at USD 1.15 billion in 2018 and is expected to reach USD 1.54 billion by year 2026, at a CAGR of 3.7%. The study covers drivers impacting the market growth, obstruction of the market and upcoming opportunities of the cortisone market. Cortisone is a naturally occurring glucocorticoid that reduces the body immune response. Cortisone is an inactive agent itself but get converted into an active metabolite hydrocortisone into liver.

Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/2088

Companies considered and profiled in this market study

Pfizer Inc., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Perrigo Company plc, Valeant Pharmaceuticals, Crown Pharmaceuticals, Aptalis Pharma Canada Inc., ANI Pharmaceuticals, Inc., Merit Pharmaceutical, Sandoz

The glucocorticoid (cortisone) work through the glucocorticoid receptors, inhibiting molecules responsible for inflammation. Cortisone shots or an injection form of cortisone is used as an orexigenic to boost the appetite in cancer patients. Moreover, this steroid hormone is not considered as oncogenic, glucocorticoid inhibit the growth and the cell apoptosis in lymphoid system it is used as anti-cancer treatment for leukemia, lymphoma, multiple myeloma. According to the estimation approximately in 2019 1,762,450 new cancer cases is expected to be diagnosed in the US, an estimation in observed approximately 74,200 new incidences of Non-Hodgkin lymphoma and 8,110 new incidences of Hodgkin lymphoma is expected to be encountered in the US. Lymphoma is a type of cancer which originates in lymph system and may spread to another lymph system.

Cortisone is applicable in allergic reactions such as asthma, allergic rhinitis. In such cases the respiratory track swells and produces extra muscle as a response of overactive immune system. Cortisone reduces the inflammation in the path. Cortisone is not recommended in specific circumstances such as insomnia, nausea, heartburn, muscle weakness, weakened wound healing mechanism, increased blood sugar and blood pressure. Cortisone tends to retain the body fluid and increases the body blood volume, increasing the blood pressure of an individual which can prove fatal in some cases.

Further key findings from the report suggest

1. During 2019-2026, Cortisone market is expected to register a CAGR of 3% in Asia Pacific; followed by North America and Europe, with 3.6% and 3.4% CAGR, respectively. High prevalence of infectious diseases across the globe is the major factor driving the market during the forecast period across all regions.

2. Asia Pacific is expected to account for the CAGR 4.3% of the global Cortisone market. Developing nations such China, and India are likely to witness high growth due to high geriatric population, and high prevalence of target diseases in the region

3. The Rheumatoid Arthritis segment dominates the market as of 2018. It is estimated to grow at a CAGR of 4.2% during the forecast period, owing it to rise in auto-immunity and geriatric population across the globe reporting highest arthritic population

4. Slow rate of commercialization, reluctance toward the adoption of new treatment practices and launch of new product are among the key factors likely to hamper growth of the market

5. The injection route for the administration of Cortisone (Cortisone shots) segment is forecasted to be the fastest growing market segment, estimated to witness a CAGR of 3.8%.

To get this report with detailed market information, tables, charts, graphs, etc., reach us here: https://www.reportsanddata.com/checkout-form/2088

For the purpose of this report, Reports and Data has segmented the Cortisone market on the basis of formulation, route of administration, route of administration, application, patient use, and region:

Formulation Outlook (Revenue, USD Million; 2016-2026)

Tablet
Injection
Eye Ointment
Eye Drop
Cream and Ointment
Enema
Patch

Route of Administration Outlook (Revenue, USD Million; 2016-2026)

Oral
Parenteral
Rectal
Ocular
Topical

Application Outlook (Revenue, USD Million; 2016-2026)

Cancer
Back pain
Bursitis
Gout
Osteoarthritis
Psoriatic Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Others

Patient Use Outlook (Revenue, USD Million; 2016-2026)

Adult
Pediatric

Regional Outlook (Revenue, USD Million; 2016-2026)

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the market: https://www.reportsanddata.com/report-detail/cortisone-market

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.